Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Tudor Investment Corporation »

Outlook Therapeutics shares owned by Tudor Investment Corporation

Quarter-by-quarter ownership of Outlook Therapeutics (OTLK) shares owned by Tudor Investment Corporation from 13F filings

Historical chart of Tudor Investment Corporation investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by Tudor Investment Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download consolidated filings csv

Download as Excel

Download consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by Tudor Investment Corporation

Quarter filed	Position value	Share count	Share price at filing
2025-09-30	$27k	25k	1.06

More positions owned by Tudor Investment Corporation

Ishares Russell 2000 Etf - US ETP ETF Option Call Option (IWM)

Invesco Qqq Trust Series 1 - US ETP ETF Option Call Option (QQQ)

Spdr S&P 500 Etf Trust - US ETP ETF Option Call Option (SPY)

Energy Select Sector Spdr Fund - US ETP ETF Option Call Option (XLE)

Ishares China Large-Cap Etf - US ETP ETF Option Call Option (FXI)

Nvidia Corp - US Equity (NVDA)

Ishares Msci Emerging Markets Etf - US ETP ETF Option Call Option (EEM)

Unitedhealth Group Inc - US Equity (UNH)

Utilities Select Sector Spdr Fund - US ETP ETF Option Call Option (XLU)

Financial Select Sector Spdr Fund - US ETP ETF Option Call Option (XLF)

Palantir Technologies Inc - US Equity (PLTR)

Oracle Corp - US Equity Option Call Option (ORCL)

Micron Technology Inc - US Equity (MU)

Goldman Sachs Group Inc/The - US Equity Option Call Option (GS)

Apple Inc - US Equity (AAPL)

View all positions for Tudor Investment Corporation

Top funds holding Outlook Therapeutics

Schonfeld Strategic Advisors

Geode Capital Management

Susquehanna International

Millennium Management

Commonwealth Equity Services

Simplex Trading

State Street Corporation

Citadel Advisors

Goldman Sachs Group

View all funds holding Outlook Therapeutics

© 2025 stockzoa - Track 13F-HR Filings for Hedge Funds and Value Investors.

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z